A AddLife AB
A
Cerrado
153 0.2
Resumen
Variación precio
24h
Mínimo
151.3
Máximo
159.1
Ingresos | -31M 229M |
|---|---|
Ventas | -88M 2.6B |
P/B Media del Sector | 30.753 105.305 |
BPA | 1.04 |
Rentabilidad por dividendo | 1.05 |
Margen de beneficios | 8.658 |
Empleados | 2,295 |
EBITDA | -373M 229M |
Rentabilidad por dividendo Media del Sector | 1.05% 2.40% |
|---|
Capitalización Mercado | -158M 17B |
|---|---|
Apertura anterior | 152.8 |
Cierre anterior | 153 |
AddLife AB Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
AddLife AB previsión
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
